![JCM | Free Full-Text | Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments JCM | Free Full-Text | Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments](https://www.mdpi.com/jcm/jcm-11-04359/article_deploy/html/images/jcm-11-04359-g001.png)
JCM | Free Full-Text | Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments
![Brain Sciences | Free Full-Text | Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease Brain Sciences | Free Full-Text | Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease](https://www.mdpi.com/brainsci/brainsci-11-00826/article_deploy/html/images/brainsci-11-00826-g001.png)
Brain Sciences | Free Full-Text | Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease
The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore | Chemical Reviews
Katalin Karikó on LinkedIn: Communiqué de presse : 16 nouveaux associés étrangers élus à l'Académie… | 148 comments
ADATKEZELÉSI TÁJÉKOZTATÓ AZ ÜGYFELEKET ÉRINTŐ ADATKEZELÉSEKRŐL DATA PRIVACY NOTICE CONCERNING CUSTOMERS' DATA
![Pharmaceuticals | Free Full-Text | Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study Pharmaceuticals | Free Full-Text | Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00598/article_deploy/html/images/pharmaceuticals-15-00598-g001-550.jpg)
Pharmaceuticals | Free Full-Text | Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study
![PDF) Hungarian translation of four additional items for the Addictive Features section of the Ottawa Self-injury Inventory version 3.1 PDF) Hungarian translation of four additional items for the Addictive Features section of the Ottawa Self-injury Inventory version 3.1](https://i1.rgstatic.net/publication/325949796_Hungarian_translation_of_four_additional_items_for_the_Addictive_Features_section_of_the_Ottawa_Self-injury_Inventory_version_31/links/5b3cfe3faca2720785118775/largepreview.png)
PDF) Hungarian translation of four additional items for the Addictive Features section of the Ottawa Self-injury Inventory version 3.1
![Pharmaceuticals | Free Full-Text | Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study Pharmaceuticals | Free Full-Text | Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00598/article_deploy/html/images/pharmaceuticals-15-00598-g002a.png)